Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950-2005 - PubMed (original) (raw)
Comparative Study
. 2008 Jan;98(1-3):287-94.
doi: 10.1016/j.schres.2007.10.005. Epub 2007 Nov 26.
Affiliations
- PMID: 18031996
- DOI: 10.1016/j.schres.2007.10.005
Comparative Study
Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950-2005
Rebecca M Capasso et al. Schizophr Res. 2008 Jan.
Abstract
Introduction: Increased mortality in people with schizophrenia, compared to the general population, has been consistently reported worldwide. This mortality has been attributed predominantly to "unnatural" deaths-suicide, accidents, and homicide. Recent studies have shown an increase in natural causes of death. Our objective is to compare the mortality of schizophrenic and schizoaffective subjects to the general US population.
Methods: 319 Olmsted County residents meeting DSM-IV-TR criteria for schizophrenia or schizoaffective disorder seen at the Mayo Clinic between 1950 and 1980 were followed until February 2005 for a median of 23.5 years.
Results: At the end of follow-up, 44% of patients were deceased. Mortality was significantly (p<0.001) increased compared to the Caucasian population in the US for persons of like age, gender, and calendar year of birth. The median survival following diagnosis was 36.2 years. Death certificate cited cause of death was cardiac (29%), cancer--including lung (19%), and pulmonary disease (17%). Concerningly, there was no association with the year of diagnosis to survival.
Conclusions: Tsuang and colleagues showed in 1975 that mortality in schizophrenics and later, those with schizoaffective disorder was significantly increased compared to the US general population. Thirty years later, with a demographically similar population, we have found the same pattern of increased mortality. In light of continued improvements in the general population's lifespan, the survival gap in schizophrenia/schizoaffective disorder appears to be increasing.
Similar articles
- [Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients].
Bralet MC, Yon V, Loas G, Noisette C. Bralet MC, et al. Encephale. 2000 Nov-Dec;26(6):32-41. Encephale. 2000. PMID: 11217537 French. - What is specific to suicide in schizophrenia disorder? Demographic, clinical and behavioural dimensions.
McGirr A, Turecki G. McGirr A, et al. Schizophr Res. 2008 Jan;98(1-3):217-24. doi: 10.1016/j.schres.2007.09.009. Epub 2007 Oct 22. Schizophr Res. 2008. PMID: 17942279 - Diagnostic profile and suicide risk in schizophrenia spectrum disorder.
Reutfors J, Bahmanyar S, Jönsson EG, Ekbom A, Nordström P, Brandt L, Ösby U. Reutfors J, et al. Schizophr Res. 2010 Nov;123(2-3):251-6. doi: 10.1016/j.schres.2010.07.014. Epub 2010 Aug 7. Schizophr Res. 2010. PMID: 20692815 - Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder.
Pagel T, Baldessarini RJ, Franklin J, Baethge C. Pagel T, et al. Bipolar Disord. 2013 May;15(3):229-39. doi: 10.1111/bdi.12057. Epub 2013 Mar 26. Bipolar Disord. 2013. PMID: 23528024 Review. - A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?
Saha S, Chant D, McGrath J. Saha S, et al. Arch Gen Psychiatry. 2007 Oct;64(10):1123-31. doi: 10.1001/archpsyc.64.10.1123. Arch Gen Psychiatry. 2007. PMID: 17909124 Review.
Cited by
- A Case of Risperidone-Induced Urinary Incontinence.
Eierman AC, Reischman AE, Gouthro RV. Eierman AC, et al. Cureus. 2024 Apr 19;16(4):e58590. doi: 10.7759/cureus.58590. eCollection 2024 Apr. Cureus. 2024. PMID: 38765431 Free PMC article. - Rest-activity rhythm disruption and metabolic health in schizophrenia: a cross-sectional actigraphy study of community-dwelling people living with schizophrenia and nonpsychiatric comparison participants.
Mahmood Z, Ramsey A, Kidambi N, Hernandez A, Palmer H, Liu J, Tu XM, Ancoli-Israel S, Malhotra A, Smagula S, Lee EE. Mahmood Z, et al. J Clin Sleep Med. 2024 Sep 1;20(9):1505-1516. doi: 10.5664/jcsm.11192. J Clin Sleep Med. 2024. PMID: 38661656 - Factors associated with suicide attempts in the antecedent illness trajectory of bipolar disorder and schizophrenia.
Miola A, Gardea-Reséndez M, Ortiz-Orendain J, Nunez NA, Ercis M, Coombes BJ, Salgado MF, Gruhlke PM, Michel I, Bostwick JM, McKean AJ, Ozerdem A, Frye MA. Miola A, et al. Int J Bipolar Disord. 2023 Dec 8;11(1):38. doi: 10.1186/s40345-023-00318-3. Int J Bipolar Disord. 2023. PMID: 38063942 Free PMC article. - Impact of the mental health reform in Israel on health care and mortality among people with severe mental illness.
Gal G, Levav I, Kodesh A. Gal G, et al. Soc Psychiatry Psychiatr Epidemiol. 2024 Jul;59(7):1227-1234. doi: 10.1007/s00127-023-02580-3. Epub 2023 Oct 13. Soc Psychiatry Psychiatr Epidemiol. 2024. PMID: 37831080 - Racial differences in pathways to care preceding first episode mania or psychosis: a historical cohort prodromal study.
Gardea-Resendez M, Ortiz-Orendain J, Miola A, Fuentes Salgado M, Ercis M, Coombes BJ, Gruhlke PM, Bostwick JM, Michel I, Vande Voort JL, Ozerdem A, McKean A, Frye MA, Taylor-Desir M. Gardea-Resendez M, et al. Front Psychiatry. 2023 Sep 4;14:1241071. doi: 10.3389/fpsyt.2023.1241071. eCollection 2023. Front Psychiatry. 2023. PMID: 37732076 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous